PRKCZ and hepatocellular carcinoma: [285] showed that the upregulation of cyclooxygenase‐2 in HCC promotes HCC formation by decreasing the expression of TET1, which in turn reduces the expression of the tumor suppressor genes TGFβ‐binding protein 1, adenylyl cyclase 5, and protein kinase C zeta.